Sanjeev Mahanta’s article titled “When Post-Filing Evidence to Determine Written Description Support Is Admissible: Amgen v. Sanofi”, was published in IP Watchdog, January 7, 2018.
Thank you for your interest in our firm. Before sending us an email, we ask that you please confirm your understanding of the following information. Our Web site, www.pbl.com, is intended for general use and is not legal advice. Your email is not intended to create, and our receipt of it does not create or constitute, an attorney-client relationship. Any information that you provide to anyone at our firm cannot be considered confidential or privileged unless we agree to represent you. By sending this email, you confirm that you have read and understand this notice.